Projects ordered by theme

1. Prevalence, incidence and patterns of drug use
this category includes (general and specific, including school) population surveys, estimates of problem drug use, studies on the characteristics of drug users or patterns of drug use
2. Determinants of drug use
this category includes studies on risk and protective factors for drug use
3. Consequences of drug use
this category includes studies on health, social and legal consequences of drug use
4. Responses to the drug situation
this category includes studies on demand reduction interventions such as the evaluation of interventions (treatment, prevention, etc.), the implementation of policies and laws, estimates of public expenditure and other economic topics;
5. Mechanisms of drug use and effects
this category includes neurobiological, pharmacological and behavioural studies, as well as research on the aetiology and developments of drug use
6. Supply and markets
this category includes studies on supply reduction interventions, such as law enforcement interventions, as well as studies on market characteristics, such as the availability and purity of drugs
7. Methodology issues
this category includes feasibility and validity studies and comparisons between different methodologies

Prevalence, incidence and patterns of drug use this category includes (general and specific, including school) population surveys, estimates of problem drug use, studies on the characteristics of drug users or patterns of drug use
DR/02	Action Research on methadone provision through community pharmacists in Belgium
DR/05	Feasibility study on the evaluation of treatment services for patients with dual disorders
DR/08	Effectiveness of inpatient treatment programs for dually diagnosed patients
DR/14	Meta-analysis concerning the effectiveness and efficiency of the medicinal use of cannabis
DR/15	Action Research on methadone provision through community pharmacists in Belgium
DR/17	Effectiveness and efficiency of the drugs of substitutions (SUBST-OP)
DR/26	Drug use and psychopathology in correctional settings
DR/28	Trajectoires de soins des usagers de drogues issus de minorités d'origine étrangère
DR/38	Treatment trajectories of ethnic minorities in substance abuse treatment
DR/55	Poly drug use and mental health among drug users who ask for treatment (POLYMEH)
DR/60	Use of alcohol, illegal drugs, hypnotics and tranquilizers in the Belgian population (UP TO DATE)
DR/64	CompuLsIve Computer use and Knowledge needs in Belgium: A multimethod approach (CLICK)
DR/69	Patterns of drug use among (ethnic and cultural) minorities (PADUMI)
DR/76	Understanding the dynamics and consequences of young adult substance use pathways (ALAMA-nightlife)
DR/84	Mapping the presence of and enhancing substance use treatment for migrants and ethnic minorities (MATREMI)
DR/86	Youth perceptions on recreational or non-medical use of psychoactive medications (YOUTH-PUMED)
DR/87	Prevalence and effects of performance enhancing drugs in different groups: lessons for a preventive and curative policy in Belgium (PREVPED)
DR/91	Persons with a BENZOdiazepine/Z-drugs use disorder in mental health CARE (BENZOCARE)
DR/94	Improved monitoring of the disease burden attributable to substance use (SUBOD)

Responses to the drug situation this category includes studies on demand reduction interventions such as the evaluation of interventions (treatment, prevention, etc.), the implementation of policies and laws, estimates of public expenditure and other economic topics
DR/01	Cure through substitute treatments in Belgium: development of a model for assessment of types of care and patients
DR/02	Action Research on methadone provision through community pharmacists in Belgium
DR/04	Prognosis value from an integrative model of vulnerability based on a French and Dutch adaptation of ASAM criteria in the choice of treatment method for drug addicts
DR/07	Substitute treatments in Belgium, Development of a model for assessment of types of care and patients (Phase II)
DR/08	Effectiveness of inpatient treatment programs for dually diagnosed patients
DR/09	Meta-analysis on the impact of local projects on drug-related nuisance (METAN)
DR/10	Heroin Delivery under Control: feasibility and follow-up study (DHCo)
DR/11	Problematic drug use
DR/12	Case management in the substance abuse treatment- and criminal justice system
DR/14	Meta-analysis concerning the effectiveness and efficiency of the medicinal use of cannabis
DR/15	Action Research on methadone provision through community pharmacists in Belgium
DR/17	Effectiveness and efficiency of the drugs of substitutions (SUBST-OP)
DR/19	Driving under the influence of psychoactive substances (ROPS)
DR/20	Implementation of the knowledge concerning drugs by the police and the magistracy
DR/21	Effectiveness of inpatient treatment programs for dually diagnosed patients
DR/22	Monitor integral (local) policy concerning drugs
DR/24	Drugs in figures II
DR/25	Knowledge and application of evidence-based guidelines in the treatment of substance abuse disorders
DR/28	Treatment trajectories of ethnic minorities in substance abuse treatment
DR/29	nEWS on EWS (N-EWS)
DR/33	Do's en don'ts in a comprehensive and integrated drug policy (DODONBEL)
DR/35	Feasability study about a recurring survey on drug use in the general population (HARPA)
DR/36	Essential and supplementary preconditions for the interaction of justice and drug treatment services (JUSTHULP)
DR/39	Evaluation of Crisis and Case Management (ECCAM)
DR/57	Drugs in figures (DIC III)
DR/58	Analysis and optimization of substitution treatment in Belgium (SUBANOP)
DR/59	Adapting best practice guidelines for the detection, prevention and treatment of substance abuse in children and youngsters to a local Belgian context (ADAPT_YOUTH)
DR/65	Sociale kost van legale en illegale drugs in Belgïe (SOCOST)
DR/66	Consensus building on minimal quality standards for drug demand reduction in Belgium (COMIQS.BE)
DR/68	Integrated Care for patients with Alcohol Use disorders( ICArUS)
DR/70	PRocess and Outcome Study of Prison-basEd Registration points (PROSPER)
DR/71	The Law of 2009 concerning the selling and serving of alcohol to youths: from state of the art to assessment (ALCOLAW)
DR/73	GENder-Sensitive Treatment and prevention services for Alcohol and drug useRs (GEN-STAR)
DR/75	Social prevention of drug related harms (SOCPREV)
DR/77	Assessment of alternative models of regulation alcohol marketing in Belgium (ALMOREGAL)
DR/78	Feasibility study on drug consumption rooms in Belgium (DRUGROOM)
DR/80	Recovery pathways and societal responses in the UK, Netherlands and Belgium (REC-PATH)
DR/83	The Evaluation of the Belgian Drug Policy (EVADRUG)
DR/85	Drugs at the festivals: Perceptions of prevention-, harm reduction-, care-, and law enforcement strategies (POPHARS)
DR/89	Substance Use and Mental Health care InTegration, a study of service networks in mental health and substance use disorders in Belgium, their accessibility, and the user’s needs (SUMHIT)
DR/90	Outcome Measurement and Evaluation as a Routine practice in alcohol and other drug services in Belgium (OMER-BE)
DR/93	Rebuilding Evidence on Drug Rooms (Rev-Droom )

Determinants of drug use this category includes studies on risk and protective factors for drug use
DR/06	Psychopathological effects of cannabis use: a critical analysis of the scientific data and methodologies
DR/14	Meta-analysis concerning the effectiveness and efficiency of the medicinal use of cannabis
DR/17	Effectiveness and efficiency of the drugs of substitutions (SUBST-OP)
DR/18	Longitudinal study about the impact of cannabis use on the mental and psychosocial health
DR/81	Perception, habitual use and cessation of benzodiazepines: a multi-method nethnography (BENZO-NET)

Consequences of drug use this category includes studies on health, social and legal consequences of drug use
DR/03	Drugs and Nuisance. Study of the phenomenon, the control and the effects of Drug related nuisance, all this from different perspectives
DR/06	Psychopathological effects of cannabis use: a critical analysis of the scientific data and methodologies
DR/09	Meta-analysis on the impact of local projects on drug-related nuisance (METAN)
DR/14	Meta-analysis concerning the effectiveness and efficiency of the medicinal use of cannabis
DR/18	Longitudinal study about the impact of cannabis use on the mental and psychosocial health
DR/19	Driving under the influence of psychoactive substances (ROPS)
DR/55	Poly drug use and mental health among drug users who ask for treatment (POLYMEH)
DR/91	Persons with a BENZOdiazepine/Z-drugs use disorder in mental health CARE (BENZOCARE)

Mechanisms of drug use and effects this category includes neurobiological, pharmacological and behavioural studies, as well as research on the aetiology and developments of drug use
DR/06	Psychopathological effects of cannabis use: a critical analysis of the scientific data and methodologies
DR/14	Meta-analysis concerning the effectiveness and efficiency of the medicinal use of cannabis
DR/18	Longitudinal study about the impact of cannabis use on the mental and psychosocial health
DR/55	Poly drug use and mental health among drug users who ask for treatment (POLYMEH)
DR/95	The relationship between gambling sponsorship and the normalization and prevalence of gambling (GAMSPON )

Supply and markets this category includes studies on supply reduction interventions, such as law enforcement interventions, as well as studies on market characteristics, such as the availability and purity of drugs
DR/03	Drugs and Nuisance. Study of the phenomenon, the control and the effects of Drug related nuisance, all this from different perspectives
DR/16	Effects of the different judicial treatments for drug users
DR/20	Implementation of the knowledge concerning drugs by the police and the magistracy
DR/22	Monitor integral (local) policy concerning drugs
DR/24	Drugs in figures II
DR/27	Profiling of ecstasy tablets (XTsee)
DR/29	nEWS on EWS (N-EWS)
DR/30	Definition and measurement of drug-related crime
DR/31	Chemical profiling of waste from clandestine synthetic drug production
DR/32	Cocaine and metabolites in waste and surface waters across Belgium
DR/34	Study of part of locally cultivated cannabis on Belgian market of the drug (GEOCAN)
DR/37	Trace detection of synthetic drugs production in waste waters (GEOAMP)
DR/56	Determination of the yield of an illegal indoor cannabis plantation (YILCAN)
DR/61	Drug treatment Court Ghent, qualitative outcome evaluation (QUALECT)
DR/62	Indicators for the supply of illegal drugs in Belgium (SUPMAP)
DR/63	Cannabis production in Belgium: assessment of the nature and harms, and implications for priority setting (CANMARKT)
DR/67	Hazards of illicit cannabis cultivation for public, users and intervention staff (HILCAN)
DR/70	PRocess and Outcome Study of Prison-basEd Registration points (PROSPER)
DR/74	The displacement of illicit drug markets from the Netherlands to Belgium: perception or reality? (DISMARK)
DR/79	Understanding New Psychoactive Substances (NPS) use in Belgium from a health perspective (NPS-care)
DR/82	From the alley to the web. The rise of illicit drug trade on cryptomarkets and the involvement of Belgian buyers and vendors (CRYPTODRUG)
DR/92	Market and Profit Analysis of Illicit Indoor Cannabis Cultivation and Trade (MARCANT)

Methodology issues this category includes feasibility and validity studies and comparisons between different methodologies
DR/04	Prognosis value from an integrative model of vulnerability based on a French and Dutch adaptation of ASAM criteria in the choice of treatment method for drug addicts
DR/05	Feasibility study on the evaluation of treatment services for patients with dual disorders
DR/06	Psychopathological effects of cannabis use: a critical analysis of the scientific data and methodologies
DR/11	Problematic drug use
DR/13	To establish a method for evaluating the illicit drug policy in Belgium within the health care sector
DR/25	Knowledge and application of evidence-based guidelines in the treatment of substance abuse disorders
DR/26	Drug use and psychopathology in correctional settings
DR/30	Definition and measurement of drug-related crime
DR/31	Chemical profiling of waste from clandestine synthetic drug production
DR/35	Feasability study about a recurring survey on drug use in the general population (HARPA)
DR/62	Indicators for the supply of illegal drugs in Belgium (SUPMAP)